Theory and Practice of Supersaturatable Formulations for Poorly Soluble Drugs

References

• Kawakami K . Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv. Drug Deliv. Rev.64 (6), 480–495 (2012).
   PubMed Web of Science ®Google Scholar
• Strickley RG . Solubilizing excipients in oral and injectable formulations. Pharm. Res.21 (2), 201–230 (2004).
   PubMed Web of Science ®Google Scholar
• Kawakami K Miyoshi K Ida Y . Solubilization behavior of poorly soluble drugs with combined use of gelucire 44/14 and cosolvent. J. Pharm. Sci.93 (6), 1471–1479 (2004).
   PubMed Web of Science ®Google Scholar
• Kawakami K Oda N Miyoshi K Funaki T Ida Y . Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents. Eur. J. Pharm. Sci.28 (1–2), 7–14 (2006).
   PubMed Web of Science ®Google Scholar
• Uekama K . Design and evaluation of cyclodextrin-based drug formulation. Chem. Pharm. Bull.52 (8), 900–915 (2004).
   PubMed Web of Science ®Google Scholar
• Brewster ME Loftsson T . Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev.59 (7), 645–666 (2007).
   PubMed Web of Science ®Google Scholar
• Yang G Jain N Yalkowsky SH . Combined effect of SLS and (SBE)7M-beta-CD on the solubilization of NSC-639829. Int. J. Pharm.269 (1), 141–148 (2004).
   PubMedGoogle Scholar
• Murdande SB Pikal MJ Shanker RM Bogner RH . Solubility advantage of amorphous pharmaceuticals: I. Thermodynamic analysis. J. Pharm. Sci.99 (3), 1254–1264 (2010).
   PubMed Web of Science ®Google Scholar
• Brouwers J Brewster ME Augustijns P . Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?J. Pharm. Sci.98 (8), 2549–2572 (2009).
   PubMed Web of Science ®Google Scholar
• Verreck G Vandecruys R De Conde V et al. The use of three different solid dispersion formulations–melt extrusion, film-coated beads, and a glass thermoplastic system–to improve the bioavailability of a novel microsomal triglyceride transfer protein inhibitor. J. Pharm. Sci.93 (5), 1217–1228 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang S Kawakami K Yamamoto M et al. Coaxial electrospray formulations for improving oral absorption of a poorly water-soluble drug. Mol. Pharm.8 (3), 807–813 (2011).
   PubMedGoogle Scholar
• Mah PT Laaksonen T Rades T et al. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide. Mol. Pharm.11 (1), 234–242 (2014).
   PubMedGoogle Scholar
• Alonzo DE Gao Y Zhou D et al. Dissolution and precipitation behavior of amorphous solid dispersions. J. Pharm. Sci.100 (8), 3316–3331 (2011).
   PubMed Web of Science ®Google Scholar
• Higashi K Yamamoto K Pandey MK et al. Insights into atomic-level interaction between mefenamic acid and Eudragit EPO in a supersaturated solution by high-resolution magic-angle spinning NMR spectroscopy. Mol. Pharm.11 (1), 351–357 (2014).
   PubMedGoogle Scholar
• Pongpeerapat A Wanawongthai C Tozuka Y Moribe K Yamamoto K . Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture. Int. J. Pharm.352 (1–2), 309–316 (2008).
   PubMed Web of Science ®Google Scholar
• Ueda K Higashi K Yamamoto K Moribe K . The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement. Int. J. Pharm.464 (1–2), 205–213 (2014).
   PubMedGoogle Scholar
• Yin L Hillmyer MA . Preparation and performance of hydroxypropyl methylcellulose esters of substituted succinates for in vitro supersaturation of a crystalline hydrophobic drug. Mol. Pharm.11 (1), 175–185 (2014).
   PubMedGoogle Scholar
• Kawakami K Harada T Miura K et al. Relationship between crystallization tendencies during cooling from melt and isothermal storage: toward a general understanding of physical stability of pharmaceutical glasses. Mol. Pharm.11 (6), 1835–1843 (2014).
   PubMedGoogle Scholar
• Kawakami K . Surface effects on the crystallization of ritonavir glass. J. Pharm. Sci.104 (1), 276–279 (2015).
   PubMed Web of Science ®Google Scholar
• Wegiel LA Mauer LJ Edgar KJ Taylor LS . Crystallization of amorphous solid dispersions of resveratrol during preparation and storage–impact of different polymers. J. Pharm. Sci.102 (1), 171–184 (2013).
   PubMed Web of Science ®Google Scholar
• Janssens S De Zeure A Paudel A et al. Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and Eudragit E100. Pharm. Res.27 (5), 775–785 (2010).
   PubMed Web of Science ®Google Scholar
• Guns S Dereymaker A Kayaert P et al. Comparison between hot-melt extrusion and spray-drying for manufacturing solid dispersions of the graft copolymer of ethylene glycol and vinylalcohol. Pharm. Res.28 (3), 673–682 (2011).
   PubMed Web of Science ®Google Scholar
• Bank M Leffingwell J Thies C . The influence of solvent upon the compatibility of polystyrene and poly(vinyl methyl ether). Macromolecules4 (1), 43–46 (1971).
   Web of Science ®Google Scholar
• Kawakami K Hasegawa Y Deguchi K et al. Competition of thermodynamic and dynamic factors during formation of multi-component particles via spray-drying. J. Pharm. Sci.102 (2), 518–529 (2013).
   PubMed Web of Science ®Google Scholar
• Gupta MK Vanwert A Bogner RH . Formation of physically stable amorphous drugs by milling with Neusilin. J. Pharm. Sci.92 (3), 536–551 (2003).
   PubMed Web of Science ®Google Scholar
• Xu W Riikonen J Lehto VP . Mesoporous systems for poorly soluble drugs. Int. J. Pharm.453 (1), 181–197 (2013).
   PubMed Web of Science ®Google Scholar
• Crowley KJ Zografi G . Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. J. Pharm. Sci.91 (2), 492–507 (2002).
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM . Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci.88 (10), 1058–1066 (1999).
   PubMed Web of Science ®Google Scholar
• Sollohub K Cal K . Spray drying technique: II. Current applications in pharmaceutical technology. J. Pharm. Sci.99 (2), 587–597 (2010).
   PubMed Web of Science ®Google Scholar
• Breitenbach J . Melt extrusion: from process to drug delivery technology. Eur. J. Pharm. Biopharm.54 (2), 107–117 (2002).
   PubMed Web of Science ®Google Scholar
• Repka MA Shah S Lu J et al. Melt extrusion: process to product. Exp. Opin. Drug Deliv.9 (1), 105–125 (2012).
   PubMed Web of Science ®Google Scholar
• Teagarden DL Baker DS . Practical aspects of lyophilization using non-aqueous co-solvent systems. Eur. J. Pharm. Sci.15 (2), 115–133 (2002).
   PubMed Web of Science ®Google Scholar
• Yasuji T Takeuchi H Kawashima Y . Particle design of poorly water-soluble substances using supercritical fluid technologies. Adv. Drug Deliv. Rev.60 (3), 388–398 (2008).
   PubMed Web of Science ®Google Scholar
• Rumondor ACF Marsac RJ Stanford LA Taylor LS . Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol. Pharm.6 (5), 1492–1505 (2009).
   PubMed Web of Science ®Google Scholar
• Marsac RJ Rumondor ACF Nivens DE et al. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone). J. Pharm. Sci.99 (1), 169–185 (2010).
   PubMed Web of Science ®Google Scholar
• Hancock BC Zografi G . The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm. Res.11 (4), 471–477 (1994).
   PubMed Web of Science ®Google Scholar
• Dong Z Chatterji A Sandhu H et al. Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation. Int. J. Pharm.355 (1–2), 141–149 (2008).
   PubMedGoogle Scholar
• Sekiguchi K Obi N . Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull.9 (11), 866–872 (1961).
   Web of Science ®Google Scholar
• Merisko-Liversidge E Liversidge GG Cooper ER . Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci.18 (2), 113–120 (2003).
   PubMed Web of Science ®Google Scholar
• Van Eedenbrugh B Van den Mooter G Augustijins P . Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int. J. Pharm.364 (1), 64–75 (2008).
   PubMedGoogle Scholar
• Kesisoglou F Panmai S Wu Y . Nanosizing–oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev.59 (7), 631–644 (2007).
   PubMed Web of Science ®Google Scholar
• Heng JYY Thielmann F Williams DR . The effects of milling on the surface properties of form I paracetamol crystals. Pharm. Res.23 (8), 1918–1927 (2006).
   PubMed Web of Science ®Google Scholar
• Desai MP Labhasetwar V Amidon GL Levy RJ . Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res.13 (12), 1838–1845 (1996).
   PubMed Web of Science ®Google Scholar
• Lai SK O'Hanlon DE Harrold S et al. Rapid Transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Natl. Acad. Sci. USA104 (5), 1482–1487 (2007).
   PubMed Web of Science ®Google Scholar
• Wanawongthai C Pongpeerapat A Higashi K et al. 2009. Nanoparticle formation from probucol/PVP/sodium alkyl sulfate co-ground mixture. Int. J. Pharm.376 (1–2), 169–175 (2009).
   PubMedGoogle Scholar
• Rasenack N Hartenhauer H Müller BW . Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int. J. Pharm.254 (2), 137–145 (2003).
   PubMed Web of Science ®Google Scholar
• De Waard H Hinrichs WLJ Frijlink HW . A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. J. Control. Release128 (2), 179–183 (2008).
   PubMed Web of Science ®Google Scholar
• Lee J Choi, JY Park CH . Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int. J. Pharm.355 (1–2), 328–336 (2008).
   PubMed Web of Science ®Google Scholar
• George M Ghosh I . Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. Eur. J. Pharm. Sci.48 (1–2), 142–152 (2013).
   PubMed Web of Science ®Google Scholar
• Abdelwahed W Degobert G Stainmesse S Fessi H . Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv. Drug Deliv. Rev.58 (15), 1688–1713 (2006).
   PubMed Web of Science ®Google Scholar
• Kawakami K Nishihara Y Hirano K . Effect of hydrophilic polymers on physical stability of liposome dispersions. J. Phys. Chem. B105 (12), 2374–2385 (2001).
   Web of Science ®Google Scholar
• Wu Y Loper A Landis E et al. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. Int. J. Pharm.285 (1–2), 135–146 (2004).
   PubMed Web of Science ®Google Scholar
• Brough C Williams III, RO . Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. Int. J. Pharm.453 (1), 157–166 (2013).
   PubMed Web of Science ®Google Scholar
• Li W Quan P Zhang Y et al. Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions. Int. J. Pharm.460 (1–2), 13–23 (2014).
   PubMed Web of Science ®Google Scholar
• Kawakami K Yoshikawa T Moroto Y et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. J. Control. Release81 (1–2), 65–74 (2002).
   PubMed Web of Science ®Google Scholar
• Lawrence MJ Rees GD . Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev.45 (1–2), 89–121 (2000).
   PubMed Web of Science ®Google Scholar
• Rane SS Anderson BD . What determines drug solubility in lipid vehicles: is it predictable?Adv. Drug Deliv. Rev.60 (6), 638–656 (2008).
   PubMed Web of Science ®Google Scholar
• Kovarik JM Mueller EA van Bree JB Tetzloff W Kutz K . Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J. Pharm. Sci.83 (3), 444–446 (1994).
   PubMed Web of Science ®Google Scholar
• Porter CJH Pouton CW Cuine JF Charman WN . Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev.60 (6), 673–691 (2008).
   PubMed Web of Science ®Google Scholar
• Porter CJH Kaukonen AM Boyd BJ Edwards GA Charman WN . Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm. Res.21 (8), 1405–1412 (2004).
   PubMed Web of Science ®Google Scholar
• Cuine JF McEvoy CL Charman WN et al. Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J. Pharm. Sci.97 (2), 995–1012 (2008).
   PubMed Web of Science ®Google Scholar
• Kawakami K Yoshikawa T Hayashi T Nishihara Y Masuda K . Microemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo study. J. Control. Release81 (1–2), 75–82 (2002).
   PubMed Web of Science ®Google Scholar
• Yang S Gursoy RN Lambert G Benita S . Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm. Res.21 (2), 261–270 (2004).
   PubMed Web of Science ®Google Scholar
• Gao P Rush BD Pfund WP et al. Development of a supersaturatable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J. Pharm. Sci.92 (12), 2386–2398 (2003).
   PubMed Web of Science ®Google Scholar
• Kawakami K . Current status of amorphous formulation and other supersaturatable dosage forms as formulations for early clinical phases. J. Pharm. Sci.98 (9), 2875–2885 (2009).
   PubMed Web of Science ®Google Scholar